Skip to main content

Table 6 Relation between ESMO-MCBS score and real-world effectiveness

From: Oncologic orphan drugs approved in the EU – do clinical trial data correspond with real-world effectiveness?

  Effectiveness  
Survival benefit > 3 months Survival benefit < 3 months, unknown magnitude or no benefit Total
ESMO-score Score A, B, 5 or 4 3 0 3
Score C, 1, 2 or 3 3 4 7
  Total 6 4 10